Get startedLog in
    Picture of HBM Healthcare Investments AG logo

    HBMN — HBM Healthcare Investments AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    FinancialsBalancedMid CapSuper Stock
    All News

    Brief: Bristol Myers Squibb To Acquire HBM Portfolio Company Turning Point Therapeutics For USD 4.1 Bln In Cash

    Picture of HBM Healthcare Investments AG logoHBM Healthcare Investments AG
    03/06/2022 16:48
    June 3 (Reuters) - HBM HEALTHCARE INVESTMENTS AG  HBMN.S :
    * BRISTOL MYERS SQUIBB TO ACQUIRE HBM PORTFOLIO COMPANY
TURNING
POINT THERAPEUTICS FOR USD 4.1 BILLION IN CASH
    * TODAY ANNOUNCES THAT ITS PORTFOLIO COMPANY TURNING POINT
THERAPEUTICS (NASDAQ: TPTX) WILL BE ACQUIRED BY BRISTOL MYERS
SQUIBB (NYSE: BMY) IN AN ALL-CASH TRANSACTION THAT VALUES
COMPANY AT USD 4.1 BILLION
    * ACQUISITION PRICE OF USD 76.-- PER SHARE REPRESENTS A
PREMIUM OF
APPROXIMATELY 122 PERCENT TO CLOSING SHARE PRICE ON 2 JUNE 2022
    * TRANSACTION IS EXPECTED TO CLOSE DURING Q3 2022

Source text for Eikon:  ID:nEQbc2xnVa 
Further company coverage:  HBMN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on HBM Healthcare Investments AG

    See all news